(Dihydro)imidazoiso[5,1-A]quinolines

Details (Dihydro)imidazoiso[5,1-A]quinolines (Dihydro)imidazoiso[5,1-A]quinolines

2010-05-25

2011-12-06

Kifle, Bruck (Department: 1622)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S211150, C514S217050, C514S232800, C514S253030, C514S292000, C540S492000, C540S544000, C540S575000, C540S597000, C544S126000, C544S361000, C546S085000, C546S086000

Reexamination Certificate

active

08071587

ABSTRACT:
The invention relates to imidazoiso[5,1-a]quinoline and 5,6-dihydro-imidazoiso[5,1-a]quinoline derivatives according to general Formula Ior a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of infertility.

REFERENCES:
patent: 6906080 (2005-06-01), Barth et al.
patent: 7858794 (2010-12-01), Timmers et al.
patent: 2002/0147345 (2002-10-01), El Tayer et al.
patent: 2008/0262033 (2008-10-01), Karstens et al.
patent: 2008/0275042 (2008-11-01), Grima Poveda et al.
patent: 2008/0300270 (2008-12-01), Timmers et al.
patent: 2009/0215773 (2009-08-01), Van Straten et al.
patent: 2011/0028450 (2011-02-01), Timmers et al.
patent: 2011/0028451 (2011-02-01), Timmers et al.
patent: 2011/0039832 (2011-02-01), van Rijn et al.
patent: 00/08015 (2000-02-01), None
patent: 00/08015 (2000-02-01), None
patent: 02/09706 (2002-02-01), None
patent: 03/004028 (2003-01-01), None
patent: 2004/014917 (2004-02-01), None
patent: 2004/014917 (2004-02-01), None
patent: 2004/031182 (2004-04-01), None
patent: 2004/056780 (2004-07-01), None
patent: 2004/056780 (2004-07-01), None
patent: 2005/087765 (2005-09-01), None
patent: 2006/117023 (2006-11-01), None
patent: 2006/117368 (2006-11-01), None
patent: 2006/117370 (2006-11-01), None
patent: 2006/117371 (2006-11-01), None
patent: 2009/098283 (2009-08-01), None
Guo, T., “Small molecule agonists and antagonists for the LH and FSH receptors”, Expert Opin. Ther. Patents, 2005, p. 1555-1564, vol. 15, No. 11.
Navot, D. et al., “The Use of Follicle-Stimulating Hormone for Controlled Ovarian Hyperstimulation in Vitro Fertilization”, Journal of in Vitro Fertilization and Embryo Transfer, 1988, p. 3-13, vol. 5, No. 1.
Olijve, W. et al., “Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon)”, Molecular Human Reproduction, 1996, p. 371-382, vol. 2, No. 5.
Sharpe, R. M., “Intratesticular Control of Steroidogenesis”, Clinical Endocrinology, 1990, p. 787-807, vol. 33.
Morse, J. H. et al., “Heterogeneity of Proteins in Commercial Preparations of Human Chorionic Gonadotropin (hCG) Demonstrated by Western Blotting”, American Journal of Reproductive Immunology, 1988, p. 134-140, vol. 17.
Devroey, P. et al., “Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH”, The Lancet, 1992, p. 1170-1171, vol. 339.
Dorrington, J. H. et al., “Effects of FSH on Gonadal Functions”, Recent Progress in Hormone Research, 1979, p. 300-342, vol. 35.
Insler, V. et al., “Gonadotropin Therapy: New Trends and Insights”, Int/Fertil, 1988, p. 85-97, vol. 33, No. 2.

Affiliated with

Also associated with

Rating

(Dihydro)imidazoiso[5,1-A]quinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (Dihydro)imidazoiso[5,1-A]quinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (Dihydro)imidazoiso[5,1-A]quinolines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4299390